SIREN : 539073221
LAVOREL MEDICARE FRANCE is a French company founded 14 years ago, specialized in the sector Activités des sociétés holding. Based in LYON (69006), this company of category ETI shows in 2024 a revenue of 1.1 M€. Find below the complete financial statements, solvency ratios, working capital requirements and sector comparison.
Data updated on 2026-05-09
Sources : INPI & INSEE SIRENE - Processing : Ministry of Economy
| Indicator | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|
| Revenue | 1 084 154 € | 1 003 783 € | 1 039 035 € | 1 171 573 € | 1 104 481 € | 288 230 € |
| Net income | -568 452 € | -175 430 € | -4 896 320 € | 18 264 € | 2 810 104 € | -3 087 305 € |
| EBITDA | 2 531 € | -20 860 € | -48 518 € | -57 424 € | -59 945 € | -57 452 € |
| Net margin | -52.4% | -17.5% | -471.2% | 1.6% | 254.4% | -1071.1% |
In 2024, LAVOREL MEDICARE FRANCE achieves revenue of 1.1 M€. Over the period 2019-2024, the company shows strong growth with a CAGR (compound annual growth rate) of +30.3%. Vs 2023: +8%. After deducting consumption (0 €), gross margin stands at 1.1 M€, i.e. a rate of 100%. This ratio measures the ability to generate value from commercial activity. EBITDA (= Gross margin - Personnel expenses - Taxes) reaches 3 k€, representing 0.2% of revenue. Positive scissor effect: EBITDA margin improves by +2.3 pts, sign of improved operational efficiency. The operating margin remains fragile, requiring cost vigilance. Net income is negative at -568 k€ (-52.4% of revenue), which will impact equity.
1 084 154 €
1 084 154 €
2 531 €
-47 346 €
-568 452 €
0.2%
The debt ratio (= Financial debt / Equity x 100) stands at 2042%. Critical situation: debt significantly exceeds equity, severely limiting borrowing capacity and exposing the company to default risk. Financial autonomy (= Equity / Total assets x 100) reaches 5%. Low autonomy: the company heavily depends on external financing (banks, suppliers).
2041.696%
4.506%
-29.536%
-31.798
1.5%
In 2024, the debt ratio of LAVOREL MEDICARE FRANCE (2041.70) ranks above the median of the sector. This ratio measures the weight of debt relative to equity. A reduction effort could improve financial strength.
In 2024, the financial autonomy of LAVOREL MEDICARE FRANCE (4.5%) ranks below the median of the sector. This ratio represents the share of equity in total financing. An improvement would strengthen the competitive position.
In 2024, the repayment capacity of LAVOREL MEDICARE FRANCE (-31.80) ranks in the bottom 25% of the sector, which is positive. This ratio indicates the number of years needed to repay debt with cash flow. A short capacity reflects controlled debt and good cash generation.
The liquidity ratio (= Current assets / Current liabilities) stands at 1765.98. Concretely, the company has €2 of liquid assets for every €1 of short-term debt: no cash risk within 12 months. The interest coverage ratio (= EBIT / Interest expenses) is 101571.0x. Operating income very largely covers interest expenses: high safety margin.
1765.976
101570.96
In 2024, the liquidity ratio of LAVOREL MEDICARE FRANCE (1765.98) ranks above the median of the sector. This ratio measures the ability to cover short-term debt with current assets. This comfortable position offers an appreciable safety margin.
In 2024, the interest coverage of LAVOREL MEDICARE FRANCE (101571.0x) ranks in the top 25% of the sector. This ratio indicates how many times operating income covers interest expenses. High coverage means financial charges weigh little on profitability.
Working capital requirement (WCR) measures the cash timing gap between customer collections and supplier/inventory payments. Average customer payment term: 131 days (formula: Customer receivables / Revenue incl. VAT x 360). Supplier term: 89 days. The gap of 42 days means the company finances its customers for over a month before being paid relative to supplier payments. This weighs on cash flow. Overall, WCR represents 1890 days of revenue, i.e. 5.7 M€ to permanently finance.
5 692 914 €
131 j
89 j
0 j
1890 j
Based on 54 transactions of similar company sales
in 2024,
the value of LAVOREL MEDICARE FRANCE is estimated at
247 019 €
(range 150 213€ - 297 748€).
With an EBITDA of 2 531€, the sector multiple of 4.8x is applied.
The price/revenue ratio is 0.59x
(in line with sector norms).
This multiples method compares the actual sale price of similar companies to their financial indicators (Revenue, EBITDA, Net Income). It provides a market-based indicative estimate.
Medium reliability: estimate to be confirmed with in-depth analysis.
Ajustez les pondérations selon votre analyse
This estimate is based on the analysis of 54 actual transactions of similar company sales (same NAF code) registered with BODACC between 2016 and 2025.
This estimate is provided for information purposes only. A precise valuation requires in-depth analysis (assets, liabilities, prospects, market...).
Compare LAVOREL MEDICARE FRANCE with other companies in the same sector:
Voir toutes les statistiques du secteur Activités des sociétés holding
The revenue of LAVOREL MEDICARE FRANCE in 2024 is 1.1 M€.
LAVOREL MEDICARE FRANCE recorded a net loss in 2024.
The headquarters of LAVOREL MEDICARE FRANCE is located in LYON (69006), in the department Rhone.
The tax return of LAVOREL MEDICARE FRANCE is available on this page. Click on a year in the 'Data by year' section to view the account details (assets, liabilities, income statement). Data comes from INPI (National Institute of Industrial Property).
LAVOREL MEDICARE FRANCE operates in the sector Activités des sociétés holding (NAF code 64.20Z). See the 'Sector positioning' section above to compare the company with its competitors.